The UK Competition Authority issues a statement of objections to three pharmaceutical companies over pay-for-delay agreements (Aspen / Amilco / Tiofarma)

On 3 October 2019 the Competition and Markets Authority (CMA) issued a Statement of Objections (the “SO”) to three pharmaceutical companies over pay-for-delay agreements in the market for Addison's disease treatment. In its SO the

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Authors

  • Bird & Bird (Amsterdam)
  • Bird & Bird (London)

Quotation

Piet-Hein Eijssen, Peter Willis, The UK Competition Authority issues a statement of objections to three pharmaceutical companies over pay-for-delay agreements (Aspen / Amilco / Tiofarma), 3 October 2019, e-Competitions October 2019, Art. N° 94004

Visites 37

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues